Limited Evidence of Functional Benefit After Upper Limb Botulinum Toxin Treatment in Children With Cerebral Palsy: Systematic Review and Meta-analysis.
Orsolya Zsuzsanna Gresits, Mátyás Vezér, Marie Anne Engh and 4 others
PMID 39789713WHAT IT FOUND
Botulinum toxin into the upper limb lowers muscle tone and spasticity in children with cerebral palsy, and parents report improvement, but the arm does not clearly work better.
Grip strength drops while the toxin is active.
Key findings
01Upper limb function did not clearly improve: pooled Melbourne Assessment and Assisting Hand Assessment scores favoured the toxin groups but neither reached statistical significance, during or after the toxin's effect.
02Muscle tone and spasticity fell significantly while the toxin was active, both at the elbow and the wrist, with high certainty evidence; by six months the difference in tone was minimal and no longer significant.
03Individualised goal scores (Goal Attainment Scaling) and COPM performance scores were significantly better with the toxin, while COPM satisfaction scores were not.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
Studies used many different upper limb and hand measures, and a sizeable number did not report data in a usable form, which made pooling and interpretation difficult or impossible. Unilateral and bilateral involvement could not be separated, even though 83% of the children had one side affected and the two groups use their arms very differently. Only single injections could be assessed; repeated injections, which are common in practice, were not evaluated. Blinding is difficult because tone visibly changes, and parents and therapists frequently guess which child was injected, so the very positive parent ratings may be inflated. Few studies reported quality of life, activity or participation, and none of those results reached significance, so the review says little about them. Publication bias could not be assessed because so few studies were available, and certainty was very low for the Assisting Hand Assessment and low for the COPM because of small patient numbers. One included study was funded entirely by the maker of Botox and eight others had partial pharmaceutical company support.
Declared interests
The review itself received no specific funding from any source and the authors declare no competing interests. Among the studies they included, eight of 14 had partial support from pharmaceutical companies and all declared the funder did not influence the study; one study was initiated and funded entirely by Allergan, the producer of Botox.
The easy way to misread this
Do not read the strong parent ratings and better goal scores as proof that the arm works better. The objective tests of upper limb function did not reach significance, the average differences were smaller than the tests can detect, and the authors themselves note that parents and therapists can usually guess which children had the injection. Grip also got weaker while the toxin was active, so a child who looks more comfortable is not necessarily a child with a stronger or more useful hand.
Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →